Bayer HealthCare
Medical Care
-
Thursday - April 12, 2012
Diabetes Care:
Bayer HealthCare aims to improve diabetes management across borders
“Excellence across Borders” program initiated » more
-
Thursday - March 1, 2012
Not intended for UK Media
Bayer HealthCare integrates its Contrast Media, Injector and Interventional businesses
New business unit named “Radiology and Interventional” broadens customer offerings and speeds up innovations / Unit encompasses leading brands Gadovist®, Ultravist®, AngioJet Ultra®, Mark 7 Arterion™ Injection System and Stellant® D CT Injection System » more
-
Wednesday - February 8, 2012
New study with Bayer’s point-of-care glycated hemoglobin analyzer:
Bayer’s A1CNow+ as accurate as standard laboratory system
Useful solution for doctor’s offices and emergency labs » more
-
Wednesday - February 8, 2012
Not intended for U.S. Media: Positive results for Bayer’s innovative blood glucose monitoring system:
Bayer’s Contour XT demonstrates analytical performance
Exceeds current ISO 15197:2003 requirements compared to conventional chemistry analyzers » more
-
Wednesday - February 8, 2012
Not intended for U.S. Media: New study with Bayer’s newest blood glucose meter:
Contour XT exceeds ISO 15197:2003 accuracy criteria
New innovative technology system provides advanced monitoring accuracy » more
-
Thursday - January 19, 2012
Bayer HealthCare Expands Research and Manufacturing Capabilities for Interventional Franchise » more
-
Tuesday - December 20, 2011
Chris Southwell participates in the world’s most famous triathlon:
Going to great lengths
Professional snowboarder and type 1 diabetic explores his limits at the Iron Man » more
-
Monday - December 5, 2011
First outcome study with Bayer’s Contour USB started
Integrated diabetes software for behavioral changes and improved glycemic control
Transforming blood glucose data into meaningful insights » more
-
Monday - December 5, 2011
International Diabetes Federation starts programme:
Young leaders to raise awareness of diabetes
Bayer HealthCare supports the IDF Young Leaders in Diabetes Programme » more
-
Friday - November 25, 2011
8th Bayer HealthCare European Diabetes Nurses Symposium:
Education can significantly improve glycaemic control
British team awarded for providing a structured pathway to reduce HbA1c levels » more
-
Tuesday - November 22, 2011
Bayer HealthCare and the Association of German Medical Journalists honor outstanding medical journalism for the ninth time
2010 European Journalists' Prize goes to Dr. Britta Julia Dombrowe and John A. Kantara » more
-
Thursday - November 17, 2011
New edition of research, the Bayer scientific magazine
Innovations from the world of research at Bayer
Personalized medicine against cancer / Creating new active crop protection ingredients with biotechnology / Electric mobility: materials for the cars of the future » more
-
Wednesday - November 16, 2011
“Perspective on Growth in Asia”
Bayer plans further expansion in Asia
Sales in the region to grow to well over EUR 11 billion by 2015 / Some EUR 6 billion in sales expected in Greater China alone / Plans to expand production, distribution network and research / Further capital expenditures of EUR 1.8 billion in Asia by 2015 / New TDI production facility dedicated in Shanghai » more
-
Monday - October 10, 2011
Study about accuracy
Contour® delivers reliable readings for diabetes self-management
Bayer’s blood glucose monitoring system exceeds ISO standard » more
-
Thursday - September 15, 2011
Medrad announces initial patient enrolled in EURO CANAL study
EURO CANAL to evaluate Cotavance® paclitaxel eluting balloon with Paccocath® technology in treating critical leg ischemia below the knee » more
-
Monday - September 12, 2011
Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011
Medrad receives CE Mark for Cotavance®
Launch of next generation of Cotavance paclitaxel coated balloon angioplasty catheter with Paccocath® technology / New Cotavance catheter platform includes improved paclitaxel coating process and dose control » more
-
Friday - August 19, 2011
Medrad announces first use of next-generation Cotavance® catheter in research setting
Cotavance® paclitaxel eluting balloon with Paccocath® technology to be evaluated in PAD patients combined with plaque excision in DEFINITIVE™ AR study » more
Copyright @ Bayer AG
Search
Links
Publications
Newsletter
Events
Download Center - Selection
